X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50773) 50773
Book Review (10558) 10558
Publication (3208) 3208
Newsletter (360) 360
Newspaper Article (163) 163
Conference Proceeding (160) 160
Book Chapter (86) 86
Book / eBook (62) 62
Dissertation (53) 53
Magazine Article (31) 31
Transcript (8) 8
Trade Publication Article (5) 5
Web Resource (4) 4
Data Set (3) 3
Paper (2) 2
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (43392) 43392
humans (42472) 42472
oncology (26988) 26988
female (21161) 21161
male (19100) 19100
lung neoplasms - drug therapy (18923) 18923
carcinoma, non-small-cell lung - drug therapy (18058) 18058
cancer (16883) 16883
middle aged (16588) 16588
aged (15506) 15506
chemotherapy (13329) 13329
lung neoplasms - pathology (11651) 11651
adult (11039) 11039
lung cancer (10464) 10464
carcinoma, non-small-cell lung - pathology (9836) 9836
animals (8602) 8602
cell line, tumor (8122) 8122
carcinoma (8063) 8063
antineoplastic combined chemotherapy protocols - therapeutic use (7975) 7975
prognosis (7851) 7851
tumors (7537) 7537
care and treatment (7516) 7516
lung cancer, non-small cell (7337) 7337
apoptosis (7221) 7221
metastasis (7196) 7196
treatment outcome (7015) 7015
antineoplastic agents - therapeutic use (6964) 6964
research (6615) 6615
expression (6389) 6389
lung neoplasms - genetics (6181) 6181
neoplasm staging (6007) 6007
carcinoma, non-small-cell lung - genetics (5765) 5765
aged, 80 and over (5754) 5754
survival (5496) 5496
analysis (5491) 5491
mice (5103) 5103
mutation (4912) 4912
cancer therapies (4839) 4839
health aspects (4783) 4783
non-small cell lung cancer (4711) 4711
cisplatin (4594) 4594
lung neoplasms - mortality (4584) 4584
gene expression (4521) 4521
respiratory system (4394) 4394
proteins (4379) 4379
genetic aspects (4374) 4374
pharmacology & pharmacy (4275) 4275
lung neoplasms - metabolism (4268) 4268
therapy (4231) 4231
antineoplastic agents - pharmacology (4222) 4222
breast-cancer (4158) 4158
carcinoma, non-small-cell lung - mortality (4113) 4113
cell biology (3831) 3831
development and progression (3718) 3718
medicine & public health (3681) 3681
carcinoma, non-small-cell lung - metabolism (3650) 3650
survival rate (3626) 3626
cell lung-cancer (3580) 3580
kinases (3570) 3570
survival analysis (3525) 3525
lung-cancer (3520) 3520
cisplatin - administration & dosage (3412) 3412
medical prognosis (3404) 3404
gefitinib (3392) 3392
immunohistochemistry (3323) 3323
hematology, oncology and palliative medicine (3285) 3285
disease-free survival (3211) 3211
patients (3165) 3165
radiotherapy (3143) 3143
retrospective studies (3135) 3135
apoptosis - drug effects (3075) 3075
medicine (3075) 3075
drug therapy (3019) 3019
combined modality therapy (2977) 2977
gene expression regulation, neoplastic (2976) 2976
adenocarcinoma (2955) 2955
signal transduction (2919) 2919
surgery (2892) 2892
research article (2891) 2891
cancer research (2852) 2852
biochemistry & molecular biology (2793) 2793
receptor, epidermal growth factor - genetics (2769) 2769
studies (2768) 2768
squamous cell carcinoma (2739) 2739
antineoplastic combined chemotherapy protocols - adverse effects (2714) 2714
cell proliferation - drug effects (2703) 2703
article (2690) 2690
protein kinase inhibitors - therapeutic use (2656) 2656
cell proliferation (2604) 2604
angiogenesis (2596) 2596
lung neoplasms - radiotherapy (2586) 2586
growth (2572) 2572
breast cancer (2509) 2509
multidisciplinary sciences (2476) 2476
trial (2467) 2467
nsclc (2461) 2461
cell cycle (2435) 2435
receptor, epidermal growth factor - antagonists & inhibitors (2413) 2413
clinical trials (2403) 2403
mice, nude (2386) 2386
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (39) 39
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Circulation Desk (3) 3
St. Michael's Hospital - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Storage (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Trillium Health Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49268) 49268
Chinese (622) 622
Japanese (565) 565
French (456) 456
German (219) 219
Italian (54) 54
Spanish (50) 50
Polish (49) 49
Russian (35) 35
Hungarian (28) 28
Czech (20) 20
Dutch (20) 20
Korean (20) 20
Portuguese (17) 17
Turkish (9) 9
Danish (8) 8
Romanian (7) 7
Serbian (6) 6
Finnish (5) 5
Swedish (3) 3
Hebrew (2) 2
Lithuanian (2) 2
Arabic (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Croatian (1) 1
Norwegian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
RESISTANT | MEDICINE, GENERAL & INTERNAL | MODELS | ANTITUMOR-ACTIVITY | INHIBITOR ALECTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Oncology, ISSN 0923-7534, 2/2009, Volume 20, Issue 2, pp. 298 - 304
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 21, pp. 2018 - 2028
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 2, pp. 123 - 135
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 976 - 983
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 17, pp. 1627 - 1639
In a randomized study involving 582 patients with advanced nonsquamous lung cancer that had progressed after primary treatment, nivolumab produced a higher... 
PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 ANTIBODY | BLOCKADE | SAFETY |